Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity

Cells(2025)10.3390/cells14090667Source: DataRank Database

Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity is a research paper published in Cells (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (8 grants)Impact (FWCI 0.00)OA: goldTopics (47)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Markus D. Siegelin ORCID,Lloyd A. Greene ORCID,Qing Zhou ORCID

Live enrichment

PubMed:40358191 PMC:PMC12071554 OpenAlex:https://openalex.org/W4410029523

NIH

Grant: R21NS137660

NIH

Grant: R01NS113793

NIH

Grant: P30CA013696

NIH HHS

Grant: 1R01NS137660-01D1

NIH HHS

Grant: 1R01NS113793-04D4

National Institutes of Health

Grant: 1R21NS137660-01

Targeting OGDH for Glioblastoma Therapy

National Institutes of Health

Grant: 3P30CA013696-21S1

CANCER CENTER CORE SUPPORT GRANT

National Institutes of Health

Grant: 5R01NS113793-02

HDAC inhibitors reverse the Warburg Effect and Elicit Metabolic Vulnerabilities in Model Systems of Glioblastoma

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://www.mdpi.com/2073-4409/14/9/667/pdf?version=1746171340

publisherhttps://www.mdpi.com/2073-4409/14/9/667/pdf?version=1746171340

publisherhttps://www.mdpi.com/2073-4409/14/9/667/pdf

journalhttps://doi.org/10.3390/cells14090667

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40358191

Fields of Study

Immune Cell Function and InteractionRNA Interference and Gene DeliveryCAR-T cell therapy research

MeSH Terms

AnimalsCytotoxicity, ImmunologicHumansKiller Cells, NaturalNeoplasmsApoptosisCCAAT-Enhancer-Binding Protein-betaCell Line, TumorActivating Transcription FactorsCell-Penetrating Peptides

Keywords

Cytotoxic T cellCytotoxicityCellCancer cellCancer researchCell cultureIn vitroBiologyCancerCell biologyBiochemistryGeneticsApoptosisPeptideNK cellsAtf5CebpdCell-penetratingNk-92mi CellsCebpbCytotoxicity, ImmunologicQH573-671CCAAT-Enhancer-Binding Protein-betaBiochemistry and Molecular BiologyBiology and Life SciencesCell-Penetrating PeptidesArticleActivating Transcription FactorsKiller Cells, NaturalCell Line, TumorNeoplasmsHumansAnimalsCytology

Sustainable Development Goals

SDG 0: Good health and well-being

Targeting ATF5, CEBPB, and CEBPD with Cell-Penetrating Dpep Sensitizes Tumor Cells to NK-92MI Cell Cytotoxicity

FAIR Checklist

Authors (3)

Funding (8 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)